These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 8750184)
21. Differential expression of CD44 variant isoforms by cell lines and tissue specimens of transitional cell carcinomas. Chuang CK; Liao SK Anticancer Res; 2003; 23(6C):4635-9. PubMed ID: 14981907 [TBL] [Abstract][Full Text] [Related]
22. CD44: structure, function, and association with the malignant process. Naor D; Sionov RV; Ish-Shalom D Adv Cancer Res; 1997; 71():241-319. PubMed ID: 9111868 [TBL] [Abstract][Full Text] [Related]
23. Gene therapeutic approach to primary and metastatic brain tumors: I. CD44 variant pre-RNA alternative splicing as a CEPT control element. Asman DC; Dirks JF; Ge L; Resnick NM; Salvucci LA; Gau JT; Becich MJ; Cooper DL; Dougherty GJ J Neurooncol; 1995 Dec; 26(3):243-50. PubMed ID: 8750190 [TBL] [Abstract][Full Text] [Related]
24. Expression of CD44 and the pattern of CD44 alternative splicing in uveal melanoma. Danen EH; ten Berge PJ; van Muijen GN; Jager MJ; Ruiter DJ Melanoma Res; 1996 Feb; 6(1):31-5. PubMed ID: 8640067 [TBL] [Abstract][Full Text] [Related]
25. CD44 expression patterns in breast and colon tumors: a PCR-based study of splice variants. Rodriguez C; Monges G; Rouanet P; Dutrillaux B; Lefrançois D; Theillet C Int J Cancer; 1995 Oct; 64(5):347-54. PubMed ID: 7591309 [TBL] [Abstract][Full Text] [Related]
26. CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers. Olsson E; Honeth G; Bendahl PO; Saal LH; Gruvberger-Saal S; Ringnér M; Vallon-Christersson J; Jönsson G; Holm K; Lövgren K; Fernö M; Grabau D; Borg A; Hegardt C BMC Cancer; 2011 Sep; 11():418. PubMed ID: 21957977 [TBL] [Abstract][Full Text] [Related]
27. Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44. Sinn HP; Heider KH; Skroch-Angel P; von Minckwitz G; Kaufmann M; Herrlich P; Ponta H Breast Cancer Res Treat; 1995; 36(3):307-313. PubMed ID: 8573713 [TBL] [Abstract][Full Text] [Related]
29. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck. Herold-Mende C; Seiter S; Born AI; Patzelt E; Schupp M; Zöller J; Bosch FX; Zöller M J Pathol; 1996 May; 179(1):66-73. PubMed ID: 8691348 [TBL] [Abstract][Full Text] [Related]
30. Expression of exon v6-containing CD44 isoforms is related to poor prognosis of acute myelocytic leukemia. Yokota A; Ishii G; Sugaya Y; Nishimura M; Saito Y; Harigaya K Hematol Oncol; 1998 Dec; 16(4):131-41. PubMed ID: 10414233 [TBL] [Abstract][Full Text] [Related]
31. [Expression of CD44 isoforms in normal human liver and also in regenerative and neoplastic liver changes]. Seelentag WK; Flury R; Schmid M; Komminoth P; Saremaslani P; Günthert U; Heitz PU; Roth J Verh Dtsch Ges Pathol; 1995; 79():144-7. PubMed ID: 8600679 [TBL] [Abstract][Full Text] [Related]
32. Correlation of CD44S expression in renal clear cell carcinomas with subsequent tumor progression or recurrence. Gilcrease MZ; Guzman-Paz M; Niehans G; Cherwitz D; McCarthy JB; Albores-Saavedra J Cancer; 1999 Dec; 86(11):2320-6. PubMed ID: 10590373 [TBL] [Abstract][Full Text] [Related]
33. Distribution of CD44 variant isoforms in human skin: differential expression in components of benign and malignant epithelia. Hale LP; Patel DD; Clark RE; Haynes BF J Cutan Pathol; 1995 Dec; 22(6):536-45. PubMed ID: 8835172 [TBL] [Abstract][Full Text] [Related]
34. CD44 isoforms distinguish between bone marrow plasma cells from normal individuals and patients with multiple myeloma at different stages of disease. van Driel M; Günthert U; Stauder R; Joling P; Lokhorst HM; Bloem AC Leukemia; 1998 Nov; 12(11):1821-8. PubMed ID: 9823960 [TBL] [Abstract][Full Text] [Related]
35. Quantitative assessment of expression of cell adhesion molecule (CD44) splice variants: CD44 standard (CD44s) and v5, v6 isoforms in oral leukoplakias: an immunohistochemical study. Godge PY; Poonja LS Indian J Dent Res; 2011; 22(3):493-4. PubMed ID: 22048598 [TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical detection of adhesion molecule CD44 splice variants in lymph node metastases of cervical cancer. Kainz C; Tempfer C; Kohlberger P; Janisch S; Koelbl H; Gitsch G; Breitenecker G Int J Cancer; 1996 Jun; 69(3):170-3. PubMed ID: 8682582 [TBL] [Abstract][Full Text] [Related]
37. Differential expression of CD44 splice variants in the normal human central nervous system. Kaaijk P; Pals ST; Morsink F; Bosch DA; Troost D J Neuroimmunol; 1997 Mar; 73(1-2):70-6. PubMed ID: 9058761 [TBL] [Abstract][Full Text] [Related]
38. CD44 variant expression and estrogen receptor status in breast cancer. Hole AK; Belkhiri A; Snell LS; Watson PH Breast Cancer Res Treat; 1997 Apr; 43(2):165-73. PubMed ID: 9131272 [TBL] [Abstract][Full Text] [Related]
39. Expression of CD44 splice variants during lymphocyte activation and tumor progression. Griffioen AW; Horst E; Heider KH; Wielenga VJ; Adolf GR; Herrlich P; Pals ST Cell Adhes Commun; 1994 Jul; 2(3):195-200. PubMed ID: 7530151 [TBL] [Abstract][Full Text] [Related]
40. Expression of CD44 variant isoforms in peripheral blood leukocytes in malignant lymphoma and leukemia: inverse correlation between expression and tumor progression. Khaldoyanidi S; Achtnich M; Hehlmann R; Zöller M Leuk Res; 1996 Oct; 20(10):839-51. PubMed ID: 8960109 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]